Literature DB >> 18027277

Swedish guidelines for diagnosis and treatment of infective endocarditis.

Katarina Westling1, Ewa Aufwerber, Christer Ekdahl, Göran Friman, Bengt Gårdlund, Inger Julander, Lars Olaison, Christina Olesund, Hanna Rundström, Ulrika Snygg-Martin, Anders Thalme, Maria Werner, Harriet Hogevik.   

Abstract

Swedish guidelines for diagnosis and treatment of infective endocarditis (IE) by consensus of experts are based on clinical experience and reports from the literature. Recommendations are evidence based. For diagnosis 3 blood cultures should be drawn; chest X-ray, electrocardiogram, and echocardiography preferably transoesophageal should be carried out. Blood cultures should be kept for 5 d and precede intravenous antibiotic therapy. In patients with native valves and suspicion of staphylococcal aetiology, cloxacillin and gentamicin should be given as empirical treatment. If non-staphylococcal etiology is most probable, penicillin G and gentamicin treatment should be started. In patients with prosthetic valves treatment with vancomycin, gentamicin and rifampicin is recommended. Patients with blood culture negative IE are recommended penicillin G (changed to cefuroxime in treatment failure) and gentamicin for native valve IE and vancomycin, gentamicin and rifampicin for prosthetic valve IE, respectively. Isolates of viridans group streptococci and enterococci should be subtyped and MIC should be determined for penicillin G and aminoglycosides. Antibiotic treatment should be chosen according to sensitivity pattern given 2-6 weeks intravenously. Cardiac valve surgery should be considered early, especially in patients with left-sided IE and/or prosthetic heart valves. Absolute indications for surgery are severe heart failure, paravalvular abscess, lack of response to antibiotic therapy, unstable prosthesis and multiple embolies. Follow-up echocardiography should be performed on clinical indications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18027277     DOI: 10.1080/00365540701534517

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

1.  Chromosomally and Extrachromosomally Mediated High-Level Gentamicin Resistance in Streptococcus agalactiae.

Authors:  Parham Sendi; Martina Furitsch; Stefanie Mauerer; Carlos Florindo; Barbara C Kahl; Sarah Shabayek; Reinhard Berner; Barbara Spellerberg
Journal:  Antimicrob Agents Chemother       Date:  2016-01-04       Impact factor: 5.191

2.  Warfarin therapy and incidence of cerebrovascular complications in left-sided native valve endocarditis.

Authors:  U Snygg-Martin; R V Rasmussen; C Hassager; N E Bruun; R Andersson; L Olaison
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-21       Impact factor: 3.267

3.  Low efficacy of tobramycin in experimental Staphylococcus aureus endocarditis.

Authors:  C J Lerche; L J Christophersen; H Trøstrup; K Thomsen; P Ø Jensen; H P Hougen; H Bundgaard; N Høiby; C Moser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-10-06       Impact factor: 3.267

4.  Cardiac surgery for infective endocarditis in patients with intravenous drug use.

Authors:  Oda Bratland Østerdal; Pirjo-Riitta Salminen; Stina Jordal; Haakon Sjursen; Øystein Wendelbo; Rune Haaverstad
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-01-29

5.  Is Penicillin Plus Gentamicin Synergistic against Clinical Group B Streptococcus isolates?: An In vitro Study.

Authors:  Corinne Ruppen; Agnese Lupo; Laurent Decosterd; Parham Sendi
Journal:  Front Microbiol       Date:  2016-10-21       Impact factor: 5.640

6.  Native aortic versus mitral valve infective endocarditis: a nationwide registry study.

Authors:  Abel Van Vlasselaer; Magnus Rasmussen; Johan Nilsson; Lars Olaison; Sigurdur Ragnarsson
Journal:  Open Heart       Date:  2019-02-27

7.  An appraisal of clinical practice guidelines for the appropriate use of echocardiography for adult infective endocarditis-the timing and mode of assessment (TTE or TEE).

Authors:  Peihan Xie; Xiaodong Zhuang; Menghui Liu; Shaozhao Zhang; Jia Liu; Donghong Liu; Xinxue Liao
Journal:  BMC Infect Dis       Date:  2021-01-21       Impact factor: 3.090

8.  Cystatin C in a composite risk score for mortality in patients with infective endocarditis: a cohort study.

Authors:  Christian Bjurman; Ulrika Snygg-Martin; Lars Olaison; Michael L X Fu; Ola Hammarsten
Journal:  BMJ Open       Date:  2012-07-12       Impact factor: 2.692

9.  Is Penicillin Plus Gentamicin Synergistic Against Sessile Group B Streptococcal Isolates? An in Vivo Study With an Experimental Model of Foreign-Body Infection.

Authors:  Corinne Ruppen; Thomas Mercier; Denis Grandgirard; Stephen L Leib; Cristina El Haj; Oscar Murillo; Laurent Decosterd; Parham Sendi
Journal:  Front Microbiol       Date:  2018-05-15       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.